You want my answer? I think 50 cents after DCVAX-L receive MHRA approval. Then it will retrace to 30-35 cents due to little capital issue. If there is partnership news, it might go to above $1-$1.5 then retrace to $1. Unless there is buyout or another approval from another agency, I would say another 2-5 years, it might be $2-$5. Don't expect any pps move due to result of illegal trading issue.
What's the capacity they can treat at Sawston with flaskworks, 15000 I think. If that is at capacity whst is the value . I think just the UK and Europe could do that.
Market Data 
Markets 
AI
